Paediatric HIV and neurodevelopment in sub-Saharan Africa: a systematic review

Amina Abubakar1, Anneloes Van Baar, Fons J R Van de Vijver

  • 1Centre for Geographic Medicine Research-Coast, Kenya Medical Research Institute, Kilifi, Kenya. a.abubakarali@uvt.nl

Insights

Human immunodeficiency virus (HIV) infection in sub-Saharan African children causes significant motor, cognitive, and language impairments. Motor development is most severely affected from infancy, with language development also showing delays.

Area of Science:

  • Pediatric Neurology
  • Developmental Psychology
  • Infectious Diseases

Background:

  • Sub-Saharan Africa (SSA) faces a high burden of pediatric HIV.
  • HIV infection is known to impact neurodevelopmental outcomes in children.
  • Understanding the specific domains affected is crucial for early intervention.

Purpose of the Study:

  • To quantify the extent of motor, cognitive, language, and social-emotional impairments in children with HIV in SSA.
  • To identify which developmental domains are most significantly affected by HIV infection.

Main Methods:

  • Systematic literature search of MEDLINE and PsycINFO databases.
  • Reference list checking of existing reviews to identify all eligible studies.
  • Computation of Cohen's d effect size to measure the degree of impairment.

Main Results:

  • Analysis of six eligible reports revealed significant developmental delays.
  • Severe motor impairment (Cohen's d = 0.97) observed at 18 months.
  • Moderate cognitive delay (d = 0.67) and significant language delay (d = 0.91) noted at 18-24 months.

Conclusions:

  • HIV significantly impacts multiple domains of child development in SSA.
  • Motor development is the most severely and consistently affected domain.
  • Further research is needed to accurately assess language development due to limited evaluation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...